Suven Life Sciences Limited — Updates, 08-07-2026: General Updates
08-07-2026 | 01:10 pm
08-07-2026 | 01:10 pm
Suven Life Sciences issued 1.86 Cr shares from warrant conversion, raising Rs 248.84 Cr. Paid-up capital rose to Rs 28.26 Cr. The Board re-appointed an Independent Director and approved a new Singapore bio-pharma subsidiary with a USD 100 million investment.
No comments yet. Be the first to comment!
